51ºÚÁϳԹÏÍø

ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
51ºÚÁϳԹÏÍø

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 51ºÚÁϳԹÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

51ºÚÁϳԹÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Commentary   
  • J Alzheimers Dis Parkinsonism 2018, Vol 8(4): 447
  • DOI: 10.4172/2161-0460.1000447

Commentary: Not Aricept but Donepezil Should not Permit for Lewy Body Disease without Proper Clinical Trials

Koji Hori* and Michiho Sodenaga
Department of Neuropsychiatry, St. Marianna University, School of Medicine, , Kawasaki, Kanagawa, Japan
*Corresponding Author : Koji Hori, St. Marianna University School of Medicine, Department of Neuropsychiatry, 2-16-1 Sugao Miyamaeku Kawasaki City, Kanagawa, Japan, Tel: +81-35-632-8070, Fax: +81-35-949-7927, Email: kojihori@marianna.ac.jp

Received Date: Aug 22, 2018 / Accepted Date: Aug 24, 2018 / Published Date: Aug 31, 2018

Keywords: Alzheimer’s Disease (AD); Aricept (original medicine of Donepezil); Effective range; Lewy Body Disease (LBD)

Citation: Hori K, Sodenaga M (2018) Commentary: Not Aricept but Donepezil Should not Permit for Lewy Body Disease without Proper Clinical Trials. J Alzheimers Dis Parkinsonism 8: 447. Doi: 10.4172/2161-0460.1000447

Copyright: © 2018 Hori K, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top